Search results
ZYMUTEST HIA, IgG
Clinical suspicion of HIT during heparin therapy Clinical suspicion of vaccine-induced immune thrombotic thrombocytopenia (VITT) Heparin-dependent antibodies of the IgG isotype are those strongly associated with the clinical diagnosis of HIT. The ZYMUTEST HIA IgG assay offers then a better specificity for the clinical complication of HIT, but it has less sensitivity as cases associated with only IgM and/or IgA isotypes are missed.
CRYOcheck Chromogenic Factor IX
This chromogenic assay is intended to be used as an aid in the management of hemophilia B in individuals aged two years or older. With a limit of quantification of 0.7% FIX activity and a test range of 0–200% FIX CRYO check Chromogenic Factor IX provides unsurpassed assurance in results, especially in cases of patients with severe hemophilia B.
TRAP-6
PT-Phen™ LRT
Determination of prothrombin time (PT) in human citrated plasma with ready-for-use liquid reagents.
PT-Phen™ LRT
Determination of prothrombin time (PT) in human citrated plasma with ready-for-use liquid reagents.
PT-Phen™ LRT
Determination of prothrombin time (PT) in human citrated plasma with ready-for-use liquid reagents.
PT-Phen™ LRT
Determination of prothrombin time (PT) in human citrated plasma with ready-for-use liquid reagents.
5-ELISA Factor VIII Plus
In vitro determination of factor VIII in plasma samples or in factor VIII concentrates or biological fluids.
S-2238™
Chromogenic substrate for thrombin.
S-2222™
Chromogenic substrate for factor Xa.